About Elsker Lifescience Private Limited
Data last updated:
Elsker Lifescience Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2015PTC287843. Its GSTIN is 07AAECE1184A1Z5 (Delhi).
The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹5.47 Lakh. It is led by directors including Rakesh Ganjoo and Prakash Singh Negi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 201 Second Floor Plot No 10, Sgl Plaza D. C Chowk Sector – 9, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.37 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹4.76 Lakh (net margin 2%) and EBITDA of ₹10.7 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.
The company is associated with 1 brand: Elsker Lifescience.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elskerlifescience.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOffice No. 201 Second Floor Plot No 10, Sgl Plaza D. C Chowk Sector – 9, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Elsker Lifescience Private Limited
The main business activity of Elsker Lifescience is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elsker Lifescience Private Limited FY 2025 filings available
Elsker Lifescience Private Limited reported revenue of ₹2.37 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Elsker Lifescience Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 10% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elsker Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.76 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elsker Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elsker Lifescience are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Elsker Lifescience Private Limited
Elsker Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| 4Amd Pharmaceuticals Private Limited | ₹2.39 Cr (FY 2025) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Ednit Software Private Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Pune, Maharashtra, India |
| Assent Lifetech Private Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Darbhanga, Bihar, India |
| Gowell International Traders Private Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Kochi, Kerala, India |
| Claps Industries Private Limited | ₹2.38 Cr (FY 2024) | •••• | •••• | -42.0% | •••• | Ahmedabad, Gujarat, India |
| Elsker Lifescience Private Limited this company | ₹2.37 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Biovaliant Laboratories Private Limited | ₹2.37 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
| Himadri Health Care Pvt.Ltd. | ₹2.37 Cr (FY 2025) | •••• | •••• | 56.0% | •••• | Darjeeling, West Bengal, India |
| Rauo Healthcare Private Limited | ₹2.37 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Bangalore, Karnataka, India |
| Sauveur Drugs & Research Private Limited | ₹2.37 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Kolkata, West Bengal, India |
| Newmet Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Ghaziabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Elsker Lifescience by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Elsker Lifescience Private Limited
Elsker Lifescience Private Limited is audited by PUNEET ZAROO AND ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PUNEET ZAROO AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Elsker Lifescience Private Limited
Elsker Lifescience has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Ganjoo | Director | 22 Apr 2017 | 9 Years 5 Months | Current |
| Prakash Singh Negi | Director | 26 Nov 2015 | 10 Years 10 Months | Current |
| Raza Alam | Director | 22 Aug 2016 | 10 Years 1 Months | Current |
| Chintamani Kumar | Director | 26 Nov 2015 | 10 Years 10 Months | Current |
Ownership and Shareholding of Elsker Lifescience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elsker Lifescience Private Limited
Elsker Lifescience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Elsker Lifescience Private Limited
Elsker Lifescience operates one associated brand: Elsker Lifescience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Marketing and selling of branded prescription pharmaceutical products with a focus on innovation and value chain operations. | elskerlifescience.com |
Employees and EPFO Compliance at Elsker Lifescience Private Limited
Employment history and EPFO contributions of people linked to Elsker Lifescience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elsker Lifescience Private Limited
Elsker Lifescience Private Limited has 6 board changes on record since 2015: 4 appointments and 2 cessations. The latest: Rakesh Ganjoo ceased to be Additional Director on 01 Jun 2018.
Credit Ratings, Litigation & Regulatory Alerts for Elsker Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elsker Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elsker Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elsker Lifescience Private Limited
Elsker Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECE1184A1Z5 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elsker Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elsker Lifescience Private Limited
Elsker Lifescience is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 November 2015 (11+ years old) and is registered under CIN U74900DL2015PTC287843.
Elsker Lifescience reported revenue of ₹2.37 Cr for FY 2025 (up 10% YoY).
Elsker Lifescience has 4 current directors:
- Rakesh Ganjoo - Director
- Prakash Singh Negi - Director
- Raza Alam - Director
- Chintamani Kumar - Director
Elsker Lifescience reported a net profit of ₹4.76 Lakh (net margin 2%) and EBITDA of ₹10.7 Lakh (EBITDA margin 4.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elsker Lifescience is 10% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elsker Lifescience is 07AAECE1184A1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Elsker Lifescience is U74900DL2015PTC287843. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elsker Lifescience was incorporated on 26 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Elsker Lifescience by revenue are 4Amd Pharmaceuticals Private Limited, Ednit Software Private Limited, Assent Lifetech Private Limited, Gowell International Traders Private Limited, Claps Industries Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rakesh Ganjoo ceased to be Additional Director on 01 Jun 2018. Diwan Singh Bisht ceased to be Director on 13 Feb 2018. Rakesh Ganjoo was appointed as Director on 22 Apr 2017. Elsker Lifescience has 6 board changes on record in total.
Elsker Lifescience can be reached through the website elskerlifescience.com. Its registered office is in Delhi, India.